Weight Management & Metabolic Peptides (13 Offers)
Research peptides targeting metabolism and fat loss. This category includes compounds like Semaglutide, Tirzepatide, and AOD 9604, studied for their effects on appetite, glucose regulation, and lipid metabolism in laboratory settings.
AOD9604 5 MG INJECTION
Drug Class: Modified Synthetic Peptide Fragment
Composition:
- Active Substance: AOD9604
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
ADIPOTIDE 10 MG INJECTION
Drug Class: Synthetic Peptide / Fat Loss Agent
Composition:
- Active Substance: Adipotide (FTPP)
- Concentration: 10 mg per vial
Presentation: 2 mL glass vial
Form: Lyophilized (freeze-dried) powder
Manufacturer: Dragon Pharma
CAGRILINTIDE ACETATE 10 MG INJECTION
Drug Class: Amylin Analog
Composition:
- Active Substance: Cagrilintide Acetate
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
IPAMORELIN, TESAMORELIN 10 MG INJECTION
Drug Class: Growth Hormone-Releasing Peptide Blend
Composition:
- Active Substance: Ipamorelin 5 mg + Tesamorelin 5 mg
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
MAZDUTIDE 10 MG INJECTION
Drug Class: Dual GLP-1 (Glucagon-Like Peptide-1)
Composition:
- Active Substance: Mazdutide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
SURVODUTIDE 10 MG INJECTION
Drug Class: Dual Agonist (GLP-1 + Glucagon Receptor Agonist)
Composition:
- Active Substance: Survodutide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
AOD 9604 5 MG INJECTION
Drug Class: Synthetic Peptide Fragment
Composition:
- Active Substance: AOD 9604
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Peptide Hubs
ADIPOTIDE 10 MG INJECTION
Drug Class: Targeted Apoptotic Peptide
Composition:
- Active Substance: Adipotide (FTPP)
- Concentration: 10 mg per vial
Presentation: 2 mL Glass Vial
Form: Lyophilized (Freeze-Dried) Powder
Manufacturer: Peptide Hubs
Tested in Laboratory: View Lab Report
CAGRILINTIDE ACETATE 10 MG INJECTION
Drug Class: Synthetic Amylin Analog
Composition:
- Active Substance: Cagrilintide Acetate
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Form: Lyophilized Powder
Manufacturer: Peptide Hubs
SURVODUTIDE 10 MG INJECTION
Drug Class: GLP-1 & Glucagon Receptor Dual Agonist Peptide
Composition:
- Active Substance: Survodutide
- Concentration: 10 mg per vial
Presentation: 2 mL Vial
Form: Lyophilized Powder for Reconstitution
Manufacturer: Peptide Hubs
CAGRILINTIDE ACETATE 10 MG INJECTION
Drug Class: Amylin Analog
Composition:
- Active Substance: Cagrilintide Acetate
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Stealth Labs USA
Tested in Laboratory: View Lab Report
Shipped Without Label!
MAZDUTIDE 10 MG INJECTION
Drug Class: Dual GLP-1 (Glucagon-Like Peptide-1)
Composition:
- Active Substance: Mazdutide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Stealth Labs USA
Tested in Laboratory: View Lab Report
Shipped Without Label!
SURVODUTIDE 10 MG INJECTION
Drug Class: Human Peptide Hormone
Composition:
- Active Substance: Survodutide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Stealth Labs USA
Tested in Laboratory: View Lab Report
Shipped Without Label!
Research Peptides in Weight Management & Metabolism
Weight management and metabolic peptides represent a significant area of scientific inquiry, focusing on compounds that influence appetite, energy expenditure, and lipid processing. This category features peptides that primarily operate through key metabolic pathways, such as GLP-1 (Glucagon-Like Peptide-1) receptor agonism and growth hormone-mediated lipolysis.
Key research compounds included here are:
- GLP-1 Receptor Agonists (e.g., Semaglutide, Tirzepatide): These peptides are central to studies on glucose-dependent insulin secretion, gastric emptying inhibition, and appetite suppression in laboratory models.
- Multi-Agonists (e.g., Retatrutide): Representing the latest advancements, these molecules target multiple receptors (like GLP-1, GIP, and glucagon) simultaneously for a synergistic effect on metabolic parameters.
- Lipolytic Fragments (e.g., AOD 9604): This modified fragment of growth hormone is studied specifically for its potential to stimulate fat breakdown (lipolysis) without the growth-promoting effects of full-length GH.
Researchers utilize these peptides to investigate mechanisms related to obesity, metabolic syndrome, and type 2 diabetes. The category offers tools for exploring everything from central appetite regulation in the hypothalamus to peripheral fat cell metabolism.
All products are furnished strictly for non-human, in-vitro research applications.
